Showing results (1151-1160 of 16,174) with videos related to

Sort By:
Pageof 1,618
European Journal of Medicinal Chemistry|December 25, 2022
Trends and hotspots for European Journal of Medicinal Chemistry: A bibliometric studyHeng Zhang, Yunfan Gao, Guangcheng Fu, et al.
European Journal of Medicinal Chemistry|December 25, 2022
PROTACS: A technology with a gold rush-like atmosphereYu-Wei Wang, Li Lan, Min Wang, et al.
European Journal of Medicinal Chemistry|December 26, 2022
Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 receptor triple agonistYongliang Yuan, Zhiming Yan, Qifang Lao, et al.
European Journal of Medicinal Chemistry|January 9, 2023
Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agentsKavita Pal, Md Kausar Raza, Jenny Legac, et al.
European Journal of Medicinal Chemistry|January 9, 2023
Identification of inhibitors as drug candidates against Chagas diseaseSheila Cruz Araujo, Rafaela Molina de Angelo, Henrique Barbosa, et al.
European Journal of Medicinal Chemistry|December 28, 2022
Design, synthesis, in vitro - In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibitionHuseyin Istanbullu, Gulsah Bayraktar, Gulsah Karakaya, et al.
European Journal of Medicinal Chemistry|December 29, 2022
Discovery of novel 5-methoxybenzothiophene hydrazides as metabolically stable Clk1 inhibitors with high potency and unprecedented Clk1 isoenzyme selectivityDalia S El-Gamil, Ahmed K ElHady, Po-Jen Chen, et al.
European Journal of Medicinal Chemistry|December 30, 2022
Development of potent and selective degraders of PI5P4KγWenzhi Ji, Eric S Wang, Theresa D Manz, et al.
European Journal of Medicinal Chemistry|January 25, 2023
Discovery of new, highly potent and selective inhibitors of BuChE - design, synthesis, in vitro and in vivo evaluation and crystallography studiesDawid Panek, Anna Pasieka, Gniewomir Latacz, et al.
European Journal of Medicinal Chemistry|January 25, 2023
Discovery and pharmacological characterization of a novel benzimidazole TRPV4 antagonist with cyanocyclobutyl moietyChongyi Ai, Zhuang Wang, Pengyun Li, et al.
Pageof 1,618